CDK2 and nasopharyngeal carcinoma: By inhibiting expression of cyclin A and CDK2, PES arrests the cell cycle in G0/G1 phase in lung cancer cells [20]; however, PES induces G2/M phase arrest in nasopharyngeal carcinoma [9].